Information Journal Paper
APA:
Copy. (2017). Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. HEMATOLOGICAL ONCOLOGY, 35(S2), 290-291. SID. https://sid.ir/paper/758260/en
Vancouver:
Copy. Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. HEMATOLOGICAL ONCOLOGY[Internet]. 2017;35(S2):290-291. Available from: https://sid.ir/paper/758260/en
IEEE:
Copy, “Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL,” HEMATOLOGICAL ONCOLOGY, vol. 35, no. S2, pp. 290–291, 2017, [Online]. Available: https://sid.ir/paper/758260/en